Aug 8, 2019 | Cost Savings, MedBen Rx Advocate, Prescription, Rebates
If you’re tired of trying to figure out all of the confusing lingo and mathematics of the pharmaceutical world, MedBen Rx Advocate is for you. Our straightforward approach to pharmacy solutions has been proven to save clients money and the best part is, you only need...
Jul 14, 2019 | Account Management, Cost Savings, MedBen Rx, MedBen Rx Advocate, Rebates
Many employers get caught up in the promised savings offered by rebate guarantees… but little do they know this could actually be costing them money, for several reasons. The first issue with rebate guarantees is that the most significant rebates are associated with...
May 30, 2019 | Cost Savings, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Transparency
The MedBen Rx approach to drug pricing is straightforward. We keep client costs low by reimbursing pharmacies what they pay for prescription drugs, plus a reasonable dispensing fee. By doing so, we ensure that self-funded employers get the maximum value from their...
Mar 23, 2019 | MedBen Rx, News, Pharmacy Benefits Manager (PBM), Prescription, Rebates, Transparency
In just four years, U.S. retail prescription drug spending grew nearly 27%… a substantial increase that illustrates the need for pharmacy solutions like those available through MedBen Rx. A new report from the Pew Charitable Trusts found that annual spending on...
Feb 23, 2019 | Cost Savings, MedBen Rx, Prescription, Rebates, Specialty Drugs, Transparency
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
Jan 13, 2019 | Cost Savings, Discounts, MedBen Rx, Prescription, Rebates, Research
New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...
